Affinage

RFC4

Replication factor C subunit 4 · UniProt P35249

Length
363 aa
Mass
39.7 kDa
Annotated
2026-06-10
18 papers in source corpus 11 papers cited in narrative 11 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 6/6 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

RFC4 is a conserved subunit of the replication factor C (RFC) clamp-loader complex that couples ATP-dependent recognition of primer-template DNA to loading of the PCNA sliding clamp during DNA replication (PMID:8063832, PMID:11432854). Its ATPase domain is functionally essential: the Walker A K55 residue is required for efficient DNA-dependent clamp loading, as a K55E mutant complex loads PCNA only at very high ATP concentrations (PMID:11432854). Beyond catalysis, RFC4 physically interacts with the N-terminal domain of Rpa1 (Rpa1N), and this contact is required for both replication and the G1/S, intra-S, and G2/M DNA damage checkpoints, placing RFC4 as a sensor that is epistatic with RAD24 (PMID:11340166); consistent with this, RFC4 localizes to replicating nuclei and its loss causes checkpoint failure with aberrant chromosome condensation and premature sister chromatid separation (PMID:11438670). RFC4 is required to maintain the integrity and expression of the assembled RFC complex, and bi-allelic loss-of-function variants disrupting its C-terminal domain destabilize RFC4 and the other RFC subunits and perturb DNA replication and cell-cycle progression, defining RFC4 as the basis of a human Mendelian disorder (PMID:39106866). In cancer settings RFC4 acts in additional protein-stabilizing roles: it promotes NHEJ-mediated repair through interaction with Ku70/Ku80 (PMID:30979744), directly binds NICD1 to block CDK8/FBXW7-mediated degradation and sustain Notch signaling in a positive feedback loop (PMID:33976158), and stabilizes an STK38-BECN1 complex to drive autophagy-based temozolomide resistance (PMID:41872171). The small molecule Platycodin D binds RFC4 and reduces nuclear Notch intracellular domain accumulation, downregulating Notch signaling (PMID:42142580).

Mechanistic history

Synthesis pass · year-by-year structured walk · 11 steps
  1. 1994 Medium

    Established RFC4 as an essential structural subunit of the RFC clamp-loader and defined its first direct intra-complex contact, anchoring all later mechanism in a defined protein assembly.

    Evidence Cloning, E. coli expression, purification and interaction assay of yeast Rfc4p with Rfc3p

    PMID:8063832

    Open questions at the time
    • Does not resolve stoichiometry or architecture of the full RFC pentamer
    • No demonstration of clamp-loading activity for Rfc4 itself
  2. 2001 High

    Showed that RFC4's ATPase domain is mechanistically required for ATP-dependent clamp loading, not merely structural.

    Evidence Walker A K55E site-directed mutagenesis with in vitro ATPase, DNA binding and PCNA loading assays on reconstituted RFC complexes

    PMID:11432854

    Open questions at the time
    • Does not define order of ATP hydrolysis among RFC subunits
    • No structural model of the K55 mutant in the loading reaction
  3. 2001 High

    Linked RFC4 to checkpoint signaling by identifying a required Rpa1N interaction and placing RFC4 in the G1/S, intra-S, and G2/M checkpoints epistatic with RAD24.

    Evidence Allele-specific synthetic lethality (rfc4-2 / rfa1-t11), checkpoint and HU-sensitivity assays, RAD24 epistasis in yeast

    PMID:11340166

    Open questions at the time
    • Does not define the molecular signal RFC4 transmits to downstream checkpoint kinases
    • Interaction mapped genetically/two-hybrid, not structurally
  4. 2001 High

    Tied RFC4 protein localization to checkpoint function in a metazoan, showing chromatin association during replication and checkpoint-specific (not kinetochore) failures upon loss.

    Evidence Immunofluorescence and loss-of-function alleles in Drosophila with replication-block and DNA-damage checkpoint assays

    PMID:11438670

    Open questions at the time
    • Does not address mammalian-specific checkpoint wiring
    • Mechanism of chromatin dispersal at mitosis unexplained
  5. 1995 Medium

    Mapped the human RFC4 gene to 3q27, enabling later human genetic and disease studies.

    Evidence PCR from somatic hybrid panels and FISH

    PMID:7774928

    Open questions at the time
    • No functional information
    • No disease association at the time
  6. 2019 Medium

    Extended RFC4 function beyond replication to DNA double-strand break repair, implicating it in NHEJ through Ku70/Ku80.

    Evidence Genome-wide RNAi screen, Co-IP with Ku70/Ku80, NHEJ vs HR repair and apoptosis assays in colorectal cancer cells and xenografts

    PMID:30979744

    Open questions at the time
    • Single lab Co-IP without reciprocal/structural validation
    • Whether NHEJ role depends on intact RFC complex unclear
  7. 2021 Medium

    Revealed a non-replicative protein-stabilization role: RFC4 directly binds NICD1 to block its degradation, sustaining Notch signaling in a feedback loop driving metastasis.

    Evidence Co-IP, competitive binding and reporter assays, knockdown/overexpression, in vitro and in vivo NSCLC tumor assays

    PMID:33976158

    Open questions at the time
    • Binding interface on RFC4 not mapped
    • Whether this requires monomeric RFC4 or the RFC complex is unresolved
  8. 2024 Medium

    Established RFC4 as the cause of a human Mendelian disorder by showing C-terminal loss-of-function variants destabilize RFC4 and the whole RFC complex with replication/cell-cycle defects.

    Evidence Patient fibroblasts and RFC4-deficient HeLa cells, Western blot of RFC subunit stability, complex-formation and cell-cycle assays, cryo-EM structural interpretation

    PMID:39106866

    Open questions at the time
    • Genotype-phenotype spectrum not fully defined
    • Direct structural data on patient variants not generated
  9. 2026 Medium

    Showed RFC4 is transcriptionally inducible (via YY1) and stabilizes an STK38-BECN1 complex to activate autophagy and confer chemoresistance.

    Evidence Chromatin accessibility/ChIP-reporter for YY1, Co-IP of RFC4-STK38-BECN1, T444 phospho-deficient mutagenesis, autophagy assays and xenografts in GBM

    PMID:41872171

    Open questions at the time
    • Direct RFC4-STK38 binding interface unmapped
    • Single lab; relationship to RFC4's clamp-loader role unaddressed
  10. 2026 Medium

    Identified RFC4 as a druggable target whose engagement by Platycodin D suppresses nuclear Notch intracellular domain accumulation and Notch signaling.

    Evidence Thermal proteome profiling, CETSA, PELSA binding assays, IP-WB, proteomic and ubiquitinomic profiling

    PMID:42142580

    Open questions at the time
    • Binding site of Platycodin D on RFC4 not defined
    • Mechanistic link between PD binding and Notch nuclear exclusion not fully resolved
  11. 2026 Low

    Positioned RFC4 upstream of Wnt/beta-catenin-driven invasion and EMT in colorectal cancer.

    Evidence siRNA knockdown with proliferation/invasion/EMT assays and pharmacological BML-284 rescue, liver metastasis model

    PMID:41574400

    Open questions at the time
    • No direct binding between RFC4 and Wnt pathway components demonstrated
    • Epistasis rests on pharmacological rescue alone
    • Single lab, not independently confirmed

Open questions

Synthesis pass · forward-looking unresolved questions
  • How RFC4's canonical clamp-loader/checkpoint functions mechanistically relate to its many cancer-associated protein-stabilization roles (NICD1, Ku70/80, STK38-BECN1, Wnt) remains unresolved.
  • Unclear whether non-replicative roles require the intact RFC complex or free RFC4
  • No shared structural binding interface identified across partners

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0005198 structural molecule activity 2 GO:0140313 molecular sequestering activity 2 GO:0003677 DNA binding 1 GO:0140657 ATP-dependent activity 1
Localization
GO:0000228 nuclear chromosome 1 GO:0005634 nucleus 1
Pathway
R-HSA-1640170 Cell Cycle 3 R-HSA-162582 Signal Transduction 2 R-HSA-69306 DNA Replication 2 R-HSA-73894 DNA Repair 1 R-HSA-9612973 Autophagy 1
Complex memberships
Replication factor C (RFC) clamp-loader complex

Evidence

Reading pass · 11 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1994 RFC4 (yeast Rfc4p) encodes the 37-kDa subunit of replication factor C and is essential for yeast viability. Purified Rfc4p formed a tight complex with the Rfc3p subunit (the ATPase of RFC), establishing a direct physical interaction between these two small RFC subunits. Cloning, overexpression in E. coli, purification, biochemical characterization, protein-protein interaction assay The Journal of biological chemistry Medium 8063832
2001 The ATP-binding domain of Rfc4 (Walker A motif, K55) is essential for DNA recognition and clamp loading by RFC. The rfc4-K55E mutant complex retained PCNA interaction and clamp loading activity but only at very high ATP concentrations, indicating Rfc4's ATPase domain contributes to ATP-dependent clamp loading. Site-directed mutagenesis of Walker A motif, overproduction of mutant RFC complexes in E. coli, in vitro ATPase assay, clamp loading assay, DNA binding assay The Journal of biological chemistry High 11432854
2001 Yeast Rfc4 physically interacts with the N-terminal domain of Rpa1 (Rpa1N), and this interaction is required for both DNA replication and DNA damage checkpoint function. rfc4-2 is synthetically lethal with rfa1-t11 (an Rpa1N mutation). Rfc4 functions as a sensor in the G1/S DNA damage checkpoint, intra-S checkpoint (replication block), and G2/M DNA damage checkpoint, and is epistatic with RAD24 for DNA damage sensitivity. Yeast two-hybrid/allele-specific genetic interaction (synthetic lethality screen), hydroxyurea sensitivity, DNA damage checkpoint assays (G1/S, intra-S, G2/M), epistasis analysis with rad24 Molecular and cellular biology High 11340166
2001 Drosophila Rfc4 (DmRfc4) protein localizes to all replicating nuclei but is dispersed from chromatin during mitosis. Loss-of-function mutations in DmRfc4 cause defects in the DNA replication block and DNA damage checkpoints (not the kinetochore attachment checkpoint), leading to aberrant mitotic chromosome condensation and premature sister chromatid separation. Immunofluorescence localization in larval tissue, genetic loss-of-function analysis of two alleles, checkpoint assays with DNA replication inhibitors and DNA-damaging agents Molecular and cellular biology High 11438670
1995 The human RFC4 gene (encoding the p37 subunit of replication factor C) was mapped to chromosome band 3q27 by PCR from somatic hybrid DNA panels and fluorescence in situ hybridization. PCR amplification from somatic cell hybrid DNA panel, fluorescence in situ hybridization (FISH) Genomics Medium 7774928
2019 RFC4 promotes nonhomologous end joining (NHEJ)-mediated DNA repair in colorectal cancer cells by physically interacting with Ku70/Ku80. RFC4 knockdown increased X-ray-induced DNA damage and apoptosis, while RFC4 did not affect homologous recombination-mediated repair. Genome-wide RNAi screen, RFC4 knockdown/overexpression, Co-immunoprecipitation with Ku70/Ku80, DNA damage assays, apoptosis assay, NHEJ and HR repair assays in vitro and xenograft mouse model Clinical cancer research Medium 30979744
2021 RFC4 directly binds to the Notch1 intracellular domain (NICD1) to competitively block CDK8/FBXW7-mediated ubiquitin-proteasomal degradation of NICD1, thereby stabilizing NICD1. RFC4 is itself a transcriptional target of Notch1 signaling, forming a positive feedback loop. This RFC4–NICD1 interaction promotes NSCLC metastasis and cancer stem cell properties. Co-immunoprecipitation, competitive binding assays, transcriptional reporter assays, RFC4 overexpression/knockdown, in vitro and in vivo tumor assays Nature communications Medium 33976158
2024 Bi-allelic loss-of-function variants in RFC4 that disrupt the C-terminal domain cause destabilization and reduced expression of RFC4 protein, compromised stability of other RFC complex subunits (RFC1–5), and perturbed RFC complex formation. Cell cycle studies using RFC4-deficient HeLa cells and primary fibroblasts showed perturbation of DNA replication and cell cycle progression. Structural analysis of the cryo-EM RFC-PCNA complex suggested the variants disrupt interactions within RFC4 and/or destabilize the RFC complex. Patient-derived fibroblasts and RFC4-deficient HeLa cells, Western blot for RFC complex subunit stability, RFC complex formation assay, cryo-EM structural analysis (previously determined structure), cell cycle analysis American journal of human genetics Medium 39106866
2026 TMZ-induced chromatin accessibility allows transcription factor YY1 to bind the RFC4 promoter and upregulate RFC4 expression in GBM. RFC4 then stabilizes the kinase STK38, and the RFC4-STK38 interaction facilitates BECN1 recruitment, activating autophagy and conferring temozolomide resistance. Phosphorylation of STK38 at T444 stabilizes the RFC4-STK38-BECN1 complex; a T444 phospho-deficient mutant impairs autophagy. Chromatin accessibility assay, ChIP/reporter assay for YY1 binding, Co-immunoprecipitation of RFC4-STK38-BECN1, phospho-deficient mutagenesis, autophagy assays, in vivo xenograft with RFC4 overexpression and autophagy inhibition Nature communications Medium 41872171
2026 RFC4 silencing in colorectal cancer cells suppresses proliferation, migration, invasion, epithelial-mesenchymal transition (EMT), and Wnt/β-catenin signaling pathway activity. The Wnt/β-catenin pathway activator BML-284 partially reversed the inhibitory effects of RFC4 silencing on invasion and EMT, positioning RFC4 upstream of Wnt/β-catenin activation. RFC4 siRNA knockdown, proliferation/migration/invasion assays, EMT marker Western blot, Wnt/β-catenin pathway reporter/western blot, BML-284 rescue experiment, in vivo liver metastasis mouse model Cell biology international Low 41574400
2026 The small molecule Platycodin D (PD) binds to RFC4 (identified by thermal proteome profiling, CETSA, and PELSA), and the PD-RFC4 complex reduces nuclear entry of Notch1 and Notch3 intracellular domains, promoting their degradation via ubiquitination and downregulating Notch signaling. Thermal proteome profiling (TPP), molecular docking, CETSA, PELSA, Western blot, immunoprecipitation-Western blot (IP-WB), proteomic and ubiquitinomic profiling Molecular & cellular proteomics Medium 42142580

Source papers

Stage 0 corpus · 18 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2001 Rfc4 interacts with Rpa1 and is required for both DNA replication and DNA damage checkpoints in Saccharomyces cerevisiae. Molecular and cellular biology 95 11340166
2021 An RFC4/Notch1 signaling feedback loop promotes NSCLC metastasis and stemness. Nature communications 92 33976158
2019 Genome-wide RNAi Screening Identifies RFC4 as a Factor That Mediates Radioresistance in Colorectal Cancer by Facilitating Nonhomologous End Joining Repair. Clinical cancer research : an official journal of the American Association for Cancer Research 62 30979744
2001 ATP utilization by yeast replication factor C. III. The ATP-binding domains of Rfc2, Rfc3, and Rfc4 are essential for DNA recognition and clamp loading. The Journal of biological chemistry 58 11432854
2001 Loss of cell cycle checkpoint control in Drosophila Rfc4 mutants. Molecular and cellular biology 43 11438670
1995 Assignment of the 36.5-kDa (RFC5), 37-kDa (RFC4), 38-kDa (RFC3), and 40-kDa (RFC2) subunit genes of human replication factor C to chromosome bands 12q24.2-q24.3, 3q27, 13q12.3-q13, and 7q11.23. Genomics 40 7774928
1994 Cloning and characterization of the essential Saccharomyces cerevisiae RFC4 gene encoding the 37-kDa subunit of replication factor C. The Journal of biological chemistry 35 8063832
2022 Knockdown of RFC4 inhibits the cell proliferation of nasopharyngeal carcinoma in vitro and in vivo. Frontiers of medicine 24 36562948
2021 RFC4 promotes the progression and growth of Oral Tongue squamous cell carcinoma in vivo and vitro. Journal of clinical laboratory analysis 18 33783864
2024 Knockdown of RFC4 inhibits cell proliferation of oral squamous cell carcinoma in vitro and in vivo. FEBS open bio 6 39673181
2024 Expanding the genetic and phenotypic landscape of replication factor C complex-related disorders: RFC4 deficiency is linked to a multisystemic disorder. American journal of human genetics 3 39106866
2025 Roles of MARCKSL1, MCM6, RFC4, and PLAU genes in esophageal cancer and their association with radiotherapy response. Scientific reports 2 40603489
2024 RFC4 confers radioresistance of esophagus squamous cell carcinoma through regulating DNA damage response. American journal of physiology. Cell physiology 2 39672175
2025 Comprehensive analysis of RFC4 as a potential biomarker for regulating the immune microenvironment and predicting immune therapy response in lung adenocarcinoma. Frontiers in immunology 1 40612960
2026 RFC4 Promotes the Metastasis of Colorectal Cancer by Regulating the Wnt/β-Catenin Pathway. Cell biology international 0 41574400
2026 RFC4 drives temozolomide resistance in glioblastoma by activating STK38-BECN1-dependent autophagy. Nature communications 0 41872171
2026 Multidimensional Proteomics Reveals the Pro-apoptotic Mechanism of Platycodin D: Targeting RFC4 to Regulate the Notch Signaling Axis in Non-Small Cell Lung Cancer. Molecular & cellular proteomics : MCP 0 42142580
2025 Biallelic variants in the RFC4 gene cause a rapidly progressive congenital myopathy with severe hypotonia and axial weakness. Neuromuscular disorders : NMD 0 40327962

Missed literature

Know a paper Affinage missed for RFC4? Flag it for the maintainers and the community.

No submissions yet.